ArticlePloS one2024

Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growth.

Mira Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.